PortfoliosLab logoPortfoliosLab logo
XPH vs. FBT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XPH vs. FBT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Pharmaceuticals ETF (XPH) and First Trust Amex Biotechnology Index (FBT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XPH achieves a 22.08% return, which is significantly higher than FBT's 18.87% return. Over the past 10 years, XPH has underperformed FBT with an annualized return of 4.80%, while FBT has yielded a comparatively higher 9.38% annualized return.


XPH

1D
0.25%
1M
1.59%
6M
19.87%
YTD
22.08%
1Y
64.62%
3Y*
17.93%
5Y*
7.45%
10Y*
4.80%
ALL TIME*
9.39%

FBT

1D
0.18%
1M
-3.86%
6M
14.47%
YTD
18.87%
1Y
49.37%
3Y*
17.79%
5Y*
7.63%
10Y*
9.38%
ALL TIME*
13.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$41.76M$24.66M$18.95M
$7.06M$7.70M$5.53M

XPH vs. FBT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XPH
SPDR S&P Pharmaceuticals ETF
22.08%31.60%4.94%2.97%-9.83%-10.54%14.68%25.61%-15.32%12.05%
FBT
First Trust Amex Biotechnology Index
18.87%24.25%5.88%2.55%-4.83%-2.26%12.96%19.74%-0.30%37.07%

Correlation

The correlation between XPH and FBT is 0.71, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.71

Correlation (3Y)
Balances recent behavior with more history.

0.75

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.78

Correlation (10Y)
Provides a long-term view across more market conditions.

0.77

Correlation (All Time)
Calculated using the full available price history since Jun 23, 2006

0.76

The correlation between XPH and FBT has been stable across timeframes, ranging from 0.71 to 0.78 - a consistent structural relationship.

XPH vs. FBT - Sectors Allocation Comparison


Sectors
XPH
FBT

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

XPH
100.0%
FBT
100.0%

Basic Materials

XPH

-

FBT

-

Communication Services

XPH

-

FBT

-

Consumer Cyclical

XPH

-

FBT

-

Consumer Defensive

XPH

-

FBT

-

Energy

XPH

-

FBT

-

Financial Services

XPH

-

FBT

-

Industrials

XPH

-

FBT

-

Real Estate

XPH

-

FBT

-

Technology

XPH

-

FBT

-

Utilities

XPH

-

FBT

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XPH vs. FBT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

XPH
XPH Risk / Return Rank: 9494
Overall Rank
XPH Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 9494
Sortino Ratio Rank
XPH Omega Ratio Rank: 9292
Omega Ratio Rank
XPH Calmar Ratio Rank: 9595
Calmar Ratio Rank
XPH Martin Ratio Rank: 9494
Martin Ratio Rank

FBT
FBT Risk / Return Rank: 8686
Overall Rank
FBT Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
FBT Sortino Ratio Rank: 9090
Sortino Ratio Rank
FBT Omega Ratio Rank: 8787
Omega Ratio Rank
FBT Calmar Ratio Rank: 8686
Calmar Ratio Rank
FBT Martin Ratio Rank: 7777
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

XPH vs. FBT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Pharmaceuticals ETF (XPH) and First Trust Amex Biotechnology Index (FBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XPHFBTDifference
Sharpe ratioReturn per unit of total volatility

+0.56

Sortino ratioReturn per unit of downside risk

+0.53

Omega ratioGain probability vs. loss probability

1.46

1.39

+0.06

Calmar ratioReturn relative to maximum drawdown

5.43

3.48

+1.95

Martin ratioReturn relative to average drawdown

19.31

10.27

+9.03

XPH vs. FBT - Sharpe Ratio Comparison

The current XPH Sharpe Ratio is 2.88, which is comparable to the FBT Sharpe Ratio of 2.32. The chart below compares the historical Sharpe Ratios of XPH and FBT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

XPH vs. FBT - Drawdown Comparison

The maximum XPH drawdown since its inception was -48.03%, which is greater than FBT's maximum drawdown of -40.51%. Use the drawdown chart below to compare losses from any high point for XPH and FBT.


Loading charts...

Drawdown Indicators


XPHFBTDifference

Max Drawdown

Largest peak-to-trough decline

-48.03%

-40.51%

-7.52%

Max Drawdown (1Y)

Largest decline over 1 year

-11.97%

-14.26%

+2.29%

Max Drawdown (3Y)

Largest decline over 3 years

-23.57%

-20.05%

-3.52%

Max Drawdown (5Y)

Largest decline over 5 years

-30.92%

-28.98%

-1.94%

Max Drawdown (10Y)

Largest decline over 10 years

-35.97%

-32.37%

-3.60%

Current Drawdown

Current decline from peak

-2.60%

-4.17%

+1.57%

Average Drawdown

Average peak-to-trough decline

-17.12%

-11.09%

-6.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.36%

4.82%

-1.46%

Volatility

XPH vs. FBT - Volatility Comparison

SPDR S&P Pharmaceuticals ETF (XPH) has a higher volatility of 7.62% compared to First Trust Amex Biotechnology Index (FBT) at 5.73%. This indicates that XPH's price experiences larger fluctuations and is considered to be riskier than FBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XPHFBTDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.62%

5.73%

+1.89%

Volatility (6M)

Calculated over the trailing 6-month period

17.53%

15.96%

+1.57%

Volatility (1Y)

Calculated over the trailing 1-year period

22.59%

21.42%

+1.17%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.02%

22.01%

-0.99%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.14%

23.77%

-1.63%

XPH vs. FBT - Expense Ratio Comparison

XPH has a 0.35% expense ratio, which is lower than FBT's 0.57% expense ratio.


Dividends

XPH vs. FBT - Dividend Comparison

XPH's dividend yield for the trailing twelve months is around 0.49%, while FBT has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
FBT
First Trust Amex Biotechnology Index
0.00%0.00%0.71%0.00%0.00%1.37%0.00%0.00%0.00%0.00%0.00%0.12%
XPH
SPDR S&P Pharmaceuticals ETF
0.49%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Frequently Asked Questions


XPH and FBT have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XPH has higher volatility (7.62%) compared to FBT (5.73%). In terms of maximum drawdown, XPH dropped -48.03% vs FBT's -40.51%.

On 10-year performance, FBT leads with 9.38% vs 4.80% for XPH. On fees, XPH is cheaper at 0.35% per year. On volatility, FBT has been the lower-risk option at 5.73%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, FBT has performed better with a 9.38% return vs 4.80%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XPH is cheaper with a 0.35% expense ratio, compared with 0.57% for FBT.

XPH has the higher dividend yield at 0.49%, compared with 0.00% for FBT.

XPH tracks S&P Pharmaceuticals Select Industry Index, while FBT tracks NYSE Arca Biotechnology Index. They also come from different issuers: State Street and First Trust. Their fees differ too: 0.35% for XPH and 0.57% for FBT.

XPH currently has the higher Sharpe Ratio (2.88 vs 2.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XPH and FBT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer